Lista de obras -

(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions

artículo científico publicado en 2019

(2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism

scientific article published on 19 June 2019

(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses

artículo científico publicado en 2019

A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.

artículo científico publicado en 2017

Alpha2B-Adrenergic Receptor Overexpression in the Brain Potentiate Air Pollution-induced Behavior and Blood Pressure Changes

scientific article published on 01 May 2019

Animal models to improve our understanding and treatment of suicidal behavior

artículo científico publicado en 2017

Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function

scientific article published on 22 February 2019

Chronic nicotine administration restores brain region specific upregulation of oxytocin receptor binding levels in a G72 mouse model of schizophrenia

scientific article published on 10 October 2018

Classical conditioning of antidepressant placebo effects in mice

artículo científico publicado en 2019

Convergent Mechanisms Underlying Rapid Antidepressant Action.

artículo científico publicado en 2018

Correction to "Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites"

artículo científico publicado en 2017

Dopamine and Stress System Modulation of Sex Differences in Decision Making.

artículo científico publicado en 2017

Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters.

artículo científico publicado en 2016

Environmental enrichment enhances conditioned place preference to ethanol via an oxytocinergic-dependent mechanism in male mice

scientific article published on 21 June 2018

Group II metabotropic glutamate receptor blockade promotes stress resilience in mice

artículo científico publicado en 2019

Intracellular Signaling Pathways Involved in (S)- and (R)-Ketamine Antidepressant Actions.

artículo científico publicado en 2018

Isoflurane but not Halothane Prevents and Reverses Helpless Behavior: A Role for EEG Burst Suppression?

artículo científico publicado en 2018

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

artículo científico publicado en 2018

Mechanisms of ketamine action as an antidepressant.

artículo científico publicado en 2018

Methamphetamine withdrawal induces activation of CRF neurons in the brain stress system in parallel with an increased activity of cardiac sympathetic pathways.

artículo científico publicado en 2018

Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine

scientific article published on 29 November 2018

Oxytocin and opioid addiction revisited: old drug, new applications.

artículo científico publicado en 2017

Post-weaning A1/A2 β-casein milk intake modulates depressive-like behavior, brain μ-opioid receptors, and the metabolome of rats

artículo científico publicado en 2021

Region-specific up-regulation of oxytocin receptor binding in the brain of mice following chronic nicotine administration.

artículo científico publicado en 2015

Sex-Specific Involvement of Estrogen Receptors in Behavioral Responses to Stress and Psychomotor Activation

article

Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites.

artículo científico publicado en 2017

Transient anhedonia phenotype and altered circadian timing of behaviour during night-time dim light exposure in Per3-/- mice, but not wildtype mice.

artículo científico publicado en 2017

Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal α7 nACh receptors in mice

artículo científico publicado en 2017

Zanos et al. reply.

artículo científico publicado en 2017

Lista de obras de

(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions

(2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism

(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses

A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.

Alpha2B-Adrenergic Receptor Overexpression in the Brain Potentiate Air Pollution-induced Behavior and Blood Pressure Changes

Animal models to improve our understanding and treatment of suicidal behavior

Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function

Chronic nicotine administration restores brain region specific upregulation of oxytocin receptor binding levels in a G72 mouse model of schizophrenia

Classical conditioning of antidepressant placebo effects in mice

Convergent Mechanisms Underlying Rapid Antidepressant Action.

Correction to "Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites"

Dopamine and Stress System Modulation of Sex Differences in Decision Making.

Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters.

Environmental enrichment enhances conditioned place preference to ethanol via an oxytocinergic-dependent mechanism in male mice

Group II metabotropic glutamate receptor blockade promotes stress resilience in mice

Intracellular Signaling Pathways Involved in (S)- and (R)-Ketamine Antidepressant Actions.

Isoflurane but not Halothane Prevents and Reverses Helpless Behavior: A Role for EEG Burst Suppression?

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Mechanisms of ketamine action as an antidepressant.

Methamphetamine withdrawal induces activation of CRF neurons in the brain stress system in parallel with an increased activity of cardiac sympathetic pathways.

Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine

Oxytocin and opioid addiction revisited: old drug, new applications.

Post-weaning A1/A2 β-casein milk intake modulates depressive-like behavior, brain μ-opioid receptors, and the metabolome of rats

Region-specific up-regulation of oxytocin receptor binding in the brain of mice following chronic nicotine administration.

Sex-Specific Involvement of Estrogen Receptors in Behavioral Responses to Stress and Psychomotor Activation

Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites.

Transient anhedonia phenotype and altered circadian timing of behaviour during night-time dim light exposure in Per3-/- mice, but not wildtype mice.

Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal α7 nACh receptors in mice

Zanos et al. reply.